Most Read Articles
Jackey Suen, 19 May 2016
Researchers from The University of Hong Kong have developed a probiotic mixture that has been shown to suppress cancer growth in extraintestinal regions such as the liver. [Proc Natl Acad Sci U S A 2016;113:E1306-E1315]
Elvira Manzano, 22 Apr 2016
Patients infected with hepatitis C virus (HCV) who are in need of a transplant can safely receive a liver from an HCV-positive donor with a healthy liver biopsy, according to an analysis of outcomes spanning over 18 years.
Pank Jit Sin, 17 Apr 2015
Diagnosis and treatment of NAFLD isn’t always precise, but new developments are helping to pave the way for better management of the disease, shares a panel of experts. 
26 Apr 2016
Patients using aspirin are up to 3.6 times less likely to develop cholangiocarcinoma (CCA) compared with those unexposed to the drug, according to a recent US cohort study.

Hepatitis C Treatment Updates

26 Sep 2016
In this edition of MIMS Hepatology, we bring you recent updates in the treatment of hepatitis C, as well as highlights from two lectures presented in conjunction with the launch of Harvoni® (ledipasvir/sofosbuvir; LF Asia). 
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Jackey Suen, 19 May 2016
Researchers from The University of Hong Kong have developed a probiotic mixture that has been shown to suppress cancer growth in extraintestinal regions such as the liver. [Proc Natl Acad Sci U S A 2016;113:E1306-E1315]
Elvira Manzano, 22 Apr 2016
Patients infected with hepatitis C virus (HCV) who are in need of a transplant can safely receive a liver from an HCV-positive donor with a healthy liver biopsy, according to an analysis of outcomes spanning over 18 years.
Pank Jit Sin, 17 Apr 2015
Diagnosis and treatment of NAFLD isn’t always precise, but new developments are helping to pave the way for better management of the disease, shares a panel of experts. 
26 Apr 2016
Patients using aspirin are up to 3.6 times less likely to develop cholangiocarcinoma (CCA) compared with those unexposed to the drug, according to a recent US cohort study.